These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 8635285

  • 1. Clonally expanded CD8 T cells in patients with polymyalgia rheumatica and giant cell arteritis.
    Martinez-Taboada VM, Goronzy JJ, Weyand CM.
    Clin Immunol Immunopathol; 1996 Jun; 79(3):263-70. PubMed ID: 8635285
    [Abstract] [Full Text] [Related]

  • 2. Selective T cell receptor decrease in peripheral blood T lymphocytes of patients with polymyalgia rheumatica and giant cell arteritis.
    Lopez-Hoyos M, Bartolome-Pacheco MJ, Blanco R, Rodriguez-Valverde V, Martinez-Taboada VM.
    Ann Rheum Dis; 2004 Jan; 63(1):54-60. PubMed ID: 14672892
    [Abstract] [Full Text] [Related]

  • 3. Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review.
    Martinez-Taboada VM, Blanco R, Fito C, Pacheco MJ, Delgado-Rodriguez M, Rodriguez-Valverde V.
    Semin Arthritis Rheum; 2001 Feb; 30(4):257-71. PubMed ID: 11182026
    [Abstract] [Full Text] [Related]

  • 4. Familial aggregation of polymyalgia rheumatica and giant cell arteritis: genetic and T cell repertoire analysis.
    Bartolome MJ, Martínez-Taboda VM, Lopez-Hoyos M, Blanco R, Rodriguez-Valverde V.
    Clin Exp Rheumatol; 2001 Feb; 19(3):259-64. PubMed ID: 11407077
    [Abstract] [Full Text] [Related]

  • 5. Recognition of tissue residing antigen by T cells in vasculitic lesions of giant cell arteritis.
    Martinez-Taboada V, Hunder NN, Hunder GG, Weyand CM, Goronzy JJ.
    J Mol Med (Berl); 1996 Nov; 74(11):695-703. PubMed ID: 8956156
    [Abstract] [Full Text] [Related]

  • 6. A genetic approach to the aetiology of giant cell arteritis: depletion of the CD8+ T-lymphocyte subset in relatives of patients with polymyalgia rheumatica and arteritis temporalis.
    Johansen M, Elling P, Elling H, Olsson A.
    Clin Exp Rheumatol; 1995 Nov; 13(6):745-8. PubMed ID: 8835249
    [Abstract] [Full Text] [Related]

  • 7. Role of peripheral CD8 lymphocytes and soluble IL-2 receptor in predicting the duration of corticosteroid treatment in polymyalgia rheumatica and giant cell arteritis.
    Salvarani C, Boiardi L, Macchioni P, Rossi F, Tartoni P, Casadei Maldini M, Mancini R, Beltrandi E, Portioli I.
    Ann Rheum Dis; 1995 Aug; 54(8):640-4. PubMed ID: 7677440
    [Abstract] [Full Text] [Related]

  • 8. Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesis.
    Samson M, Audia S, Fraszczak J, Trad M, Ornetti P, Lakomy D, Ciudad M, Leguy V, Berthier S, Vinit J, Manckoundia P, Maillefert JF, Besancenot JF, Aho-Glele S, Olsson NO, Lorcerie B, Guillevin L, Mouthon L, Saas P, Bateman A, Martin L, Janikashvili N, Larmonier N, Bonnotte B.
    Arthritis Rheum; 2012 Nov; 64(11):3788-98. PubMed ID: 22833233
    [Abstract] [Full Text] [Related]

  • 9. Distinct vascular lesions in giant cell arteritis share identical T cell clonotypes.
    Weyand CM, Schönberger J, Oppitz U, Hunder NN, Hicok KC, Goronzy JJ.
    J Exp Med; 1994 Mar 01; 179(3):951-60. PubMed ID: 8113687
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis.
    Weyand CM, Hunder NN, Hicok KC, Hunder GG, Goronzy JJ.
    Arthritis Rheum; 1994 Apr 01; 37(4):514-20. PubMed ID: 8147928
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association.
    Dababneh A, Gonzalez-Gay MA, Garcia-Porrua C, Hajeer A, Thomson W, Ollier W.
    J Rheumatol; 1998 Nov 01; 25(11):2140-5. PubMed ID: 9818656
    [Abstract] [Full Text] [Related]

  • 14. [Polymyalgia rheumatica and giant cell arteritis--first results of a year-long study].
    Rovenský J, Tuchynová A, Poprac P, Blazíková S, Bosák V, Stvrtinová V.
    Vnitr Lek; 2006 Nov 01; 52(7-8):691-6. PubMed ID: 16967610
    [Abstract] [Full Text] [Related]

  • 15. Association of the CXCL9-CXCR3 and CXCL13-CXCR5 axes with B-cell trafficking in giant cell arteritis and polymyalgia rheumatica.
    Graver JC, Abdulahad W, van der Geest KSM, Heeringa P, Boots AMH, Brouwer E, Sandovici M.
    J Autoimmun; 2021 Sep 01; 123():102684. PubMed ID: 34237649
    [Abstract] [Full Text] [Related]

  • 16. Familial aggregation in giant cell arteritis and polymyalgia rheumatica: a comprehensive literature review including 4 new families.
    Liozon E, Ouattara B, Rhaiem K, Ly K, Bezanahary H, Loustaud V, Letellier P, Drouet M, Vidal E.
    Clin Exp Rheumatol; 2009 Sep 01; 27(1 Suppl 52):S89-94. PubMed ID: 19646354
    [Abstract] [Full Text] [Related]

  • 17. Circulating T cell subtypes in polymyalgia rheumatica and giant cell arteritis: variation in the percentage of CD8+ cells with prednisolone treatment.
    Pountain GD, Keogan MT, Brown DL, Hazleman BL.
    Ann Rheum Dis; 1993 Oct 01; 52(10):730-3. PubMed ID: 8257209
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The sensitivity and specificity of reduced CD8 lymphocyte levels in the diagnosis of polymyalgia rheumatica/giant cell arteritis.
    Arnold MH, Corrigall VM, Pitzalis C, Panayi GS.
    Clin Exp Rheumatol; 1993 Oct 01; 11(6):629-34. PubMed ID: 8299254
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.